E 281
Pill imprint E 281 has been identified as Metoprolol succinate extended release 25 mg.
Metoprolol is used in the treatment of high blood pressure; heart failure; angina; supraventricular tachycardia; atrial fibrillation (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy.
Metoprolol 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Metoprolol succinate extended release Images
- Imprint:
-
E 281
- Strength:
- 25 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
crospovidone
hypromellose
magnesium stearate
methacrylic acid copolymer
microcrystalline cellulose
polyethylene glycol
polysorbate
sugar spheres
magnesium silicate
titanium dioxide
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0281
Submitted by: picoto
Advertisement
More Metoprolol Succinate Extended Release resources
- Metoprolol
- Metoprolol Succinate Extended-Release Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Wolters Kluwer)
- Metoprolol Tartrate Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Cerner Multum)
- metoprolol (Cerner Multum)
- metoprolol (Micromedex) - Includes Dosage Information
- metoprolol Intravenous (Micromedex) - Includes Dosage Information
- Metoprolol Succinate (AHFS DI)
- Metoprolol Tartrate (AHFS DI)
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Tartrate Injection (FDA)
- Metoprolol (Wolters Kluwer)
Search Again
